{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:31:59Z","timestamp":1761154319418},"reference-count":26,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,4,24]],"date-time":"2002-04-24T00:00:00Z","timestamp":1019606400000},"content-version":"vor","delay-in-days":844,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2000,1]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> Important concerns with regard to in utero platelet transfusions are avoidance of volume overload and the immunomodulatory effects of residual white cells (WBCs). This study evaluated a modification of a leukocyte\u2010reduction system (LRS, Spectra, COBE BCT) for apheresis, which collects high\u2010concentration WBC\u2010reduced platelets (HCPs) for in utero transfusion.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> The LRS procedure was modified by running the platelet collection pump at specified low flow rates (Q<jats:sub>col<\/jats:sub>) for the first part of the procedure, collecting HCPs by gently purging them from the LRS chamber into a designated collection bag and then restoring the original LRS procedure settings to collect a second standard apheresis platelet concentrate (PC). Two centers carried out 32 procedures. Platelet yield, residual WBCs, and in vitro platelet function studies were evaluated.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> Platelet concentrations in 60 mL of HCPs were predictable according to Q<jats:sub>col<\/jats:sub> (r<jats:sup>2<\/jats:sup> = 0.735). HCP yields varied from 0.9 to 3.2 \u00d7 10<jats:sup>11<\/jats:sup>, depending on the desired final platelet concentrations in 60 mL, with an overall average of 1.92 \u00d7 10<jats:sup>11<\/jats:sup> (n = 32). Apheresis PCs had a mean platelet yield of 2.9 \u00d7 10<jats:sup>11<\/jats:sup> (1.3\u20104.4 \u00d7 10<jats:sup>11<\/jats:sup>, n = 20) and 3.9 \u00d7 10<jats:sup>11<\/jats:sup> (2.2\u20105.8 \u00d7 10<jats:sup>11<\/jats:sup>, n = 12) at concentrations of 1.3 \u00d7 10<jats:sup>12<\/jats:sup> per L for single\u2010needle and dual\u2010 needle procedures, respectively. Median WBC counts were 5.6 \u00d7 10<jats:sup>3<\/jats:sup> for HCPs and 2.0 \u00d7 10<jats:sup>4<\/jats:sup> for apheresis PCs, with &gt;99 percent expected to be less than 1 \u00d7 10<jats:sup>6<\/jats:sup>. HCP in vitro characteristics were equivalent to those of apheresis PCs at 24 hours after collection. In vitro performance declined over storage as a function of HCP yield. HCP pH at 22<jats:sup>o<\/jats:sup>C was maintained at a level of &gt;6.2 for more than 3 days for yields &gt;1.6 \u00d7 10<jats:sup>11<\/jats:sup>, less than 2 days for yields 1.6 to 2.2 \u00d7 10<jats:sup>11<\/jats:sup>, and less than 24 hours for yields &gt;2.2 \u00d7 10<jats:sup>11<\/jats:sup>. HCPs showed good in vitro characteristics and could be stored for 1 to 3 days, depending on the total number of platelets collected.<\/jats:p><jats:p><jats:bold>CONCLUSION:<\/jats:bold> A standard apheresis PC and an HCP requiring no secondary processing can be collected with the Spectra LRS. The platelet concentration may be determined by clinical need. HCPs meet the requirements for components that are transfused in utero.<\/jats:p>","DOI":"10.1046\/j.1537-2995.2000.40010091.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T22:40:47Z","timestamp":1047508847000},"page":"91-100","source":"Crossref","is-referenced-by-count":20,"title":["Preparation and storage characteristics of white cell\u2010reducedhigh\u2010concentration platelet concentrates collected by anapheresis system for transfusions in utero"],"prefix":"10.1111","volume":"40","author":[{"given":"L.J.","family":"Dumont","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Krailadsiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Seghatchian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.A.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.F.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,4,24]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91733-9"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199311113292005"},{"key":"e_1_2_7_4_2","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood.V92.7.2280","article-title":"The natural history of fetomaternal alloimmunization to the platelet\u2010specific antigen HPA\u20101a (PlA1, Zwa) as determined by antenatal screening.","volume":"92","author":"Williamson LM","year":"1998","journal-title":"Blood"},{"key":"e_1_2_7_5_2","first-page":"267","volume-title":"Platelet immunology: fundamental and clinical aspects","author":"Kaplan C","year":"1991"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199707033370104"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00533.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.1994.tb00265.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)90559-6"},{"key":"e_1_2_7_10_2","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1182\/blood.V81.8.2174.2174","article-title":"Antenatal management of severe feto\u2010maternal alloimmune thrombocytopenia: HLA incompatibility may affect responses to fetal platelet transfusions.","volume":"81","author":"Murphy MF","year":"1993","journal-title":"Blood"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1997.37597293878.x"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1998.381098440862.x"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1992.32692367203.x"},{"key":"e_1_2_7_14_2","first-page":"311","volume":"26","author":"Dumont LJ","year":"1996","journal-title":"Enhanced flow cytometric method for counting very low numbers of white cells in platelet products"},{"key":"e_1_2_7_15_2","first-page":"376","article-title":"Elisa evaluation of \u03b2\u2010thromboglobulin and platelet factor 4.","author":"Amiral J","year":"1986","journal-title":"Proceedings of the IVth International Meeting of Danubian League against Thrombosis and Hemorrhagic Diseases"},{"key":"e_1_2_7_16_2","first-page":"726","article-title":"The measurement of thrombospondin.","volume":"1","author":"Amiral J","year":"1990","journal-title":"Blood Coagul Fibrinol"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-3886(97)00013-1"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/09537109409006050"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1996.36196190510.x"},{"key":"e_1_2_7_20_2","first-page":"14","volume-title":"COBE Spectra Apheresis system operator's manual","year":"1996"},{"key":"e_1_2_7_21_2","volume-title":"Leucocyte\u2010depletion of blood and blood components","year":"1993"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.6.1703.1703"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.1996.tb00078.x"},{"key":"e_1_2_7_24_2","volume-title":"Standards for blood banks and transfusion services.","author":"Klein HG","year":"1996"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0955-3886(94)90153-8"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1053\/tm.1997.0110130"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199104000-00021"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1537-2995.2000.40010091.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1537-2995.2000.40010091.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T12:31:48Z","timestamp":1698582708000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1537-2995.2000.40010091.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["10.1046\/j.1537-2995.2000.40010091.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1537-2995.2000.40010091.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}